Several clinical studies have shown that urinary angiotensinogen is significantly increased in patients with CKD including IgA nephropathy [55], diabetic nephropathy [84, 87, 89], polycystic kidneys [90, 91], focal segmental glomerulosclerosis [56]. The gene discussed is AGT; the disease is IgA glomerulonephritis.